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Abstract
Background
Some 5%–15% of all women experience postpartum depression (PPD), which for many is
their first psychiatric disorder. The purpose of this study was to estimate the incidence of
postpartum affective disorder (AD), duration of treatment, and rate of subsequent postpar-
tum AD and other affective episodes in a nationwide cohort of women with no prior psychiat-
ric history.
Methods and findings
Linking information from several Danish national registers, we constructed a cohort of
457,317 primiparous mothers with first birth (and subsequent births) from 1 January 1996 to
31 December 2013 (a total of 789,068 births) and no prior psychiatric hospital contacts and/
or use of antidepressants. These women were followed from 1 January 1996 to 31 Decem-
ber 2014. Postpartum AD was defined as use of antidepressants and/or hospital contact for
PPD within 6 months after childbirth. The main outcome measures were risk of postpartum
AD, duration of treatment, and recurrence risk. We observed 4,550 (0.6%) postpartum epi-
sodes of AD. The analyses of treatment duration showed that 1 year after the initiation of
treatment for their first episode, 27.9% of women were still in treatment; after 4 years, 5.4%.
The recurrence risk of postpartum AD for women with a PPD hospital contact after first birth
was 55.4 per 100 person-years; for women with postpartum antidepressant medication after
first birth, it was 35.0 per 100 person-years. The rate of postpartum AD after second birth for
women with no history of postpartum AD was 1.2 per 100 person-years. After adjusting for
year of birth and mother’s age, women with PPD hospital contact after first birth had a 46.4
times higher rate (95% CI 31.5–68.4) and women with postpartum antidepressant medica-
tion after their first birth had a 26.9 times higher rate (95% CI 21.9–33.2) of a recurrent
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postpartum episode after their second birth compared to women with no postpartum AD his-
tory. Limitations include the use of registry data to identify cases and limited confounder
control.
Conclusions
In this study, an episode of postpartum AD was observed for 0.6% of childbirths among
women with no prior psychiatric history. The observed episodes were characterized by a rel-
atively short treatment duration, yet the women had a notably high rate of later AD and recur-
rent episodes of postpartum AD. The recurrence risk of postpartum AD was markedly
higher among women with PPD hospital contact after first birth compared to women with
postpartum antidepressant medication after first birth. Our results underline the necessity of
measures targeted at specific vulnerable groups, such as women who experience PPD as a
first psychiatric episode.
Author summary
Why was this study done?
• Postpartum depression (PPD) is a non-psychotic depressive episode occurring in the
period following delivery of a child. Depending on the inclusion criteria, it affects 5%–
15% of all women after childbirth, which makes it one of the most common postnatal
complications of childbearing. Left untreated, the disorder can have long-term implica-
tions for both mother and child, including impairment of the child’s development and
increased risk of long-term maternal depression.
• Our aim was to describe the risk of postpartum affective disorder (AD) (a broader cate-
gory that includes PPD) among women with no prior psychiatric episodes, as well as the
recurrence risk and the duration of treatment.
What did the researchers do and find?
• We linked data from the Danish national registries and constructed a cohort of 457,317
primiparous mothers with first birth (and subsequent births) from 1 January 1996 to 31
December 2013 (a total of 789,068 births) and no prior psychiatric hospital contacts
and/or use of antidepressants.
• In this study, an episode of postpartum AD was observed for 0.6% of childbirths among
women with no prior psychiatric history. The observed episodes were characterized by a
relatively short treatment duration, yet the women had a notably high rate of later AD
and recurrent episodes of postpartum AD. The recurrence risk of postpartum AD was
markedly higher among women with a PPD hospital contact after first birth than
among women with postpartum antidepressant medication use after first birth.
Postpartum affective disorder in women with no prior psychiatric history
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What do these findings mean?
• These population-based figures provide valuable guidance to physicians treating
women with PPD. The study documents the existence of a group of patients who experi-
ence elevated rates of subsequent depression and PPD following an initial PPD episode.
It underlines the seriousness of single initial episodes and highlights the necessity of
both primary and secondary preventive measures.
• Limitations include the use of registry data to identify cases, as this may result in a
group of women likely to be at the more severe end of the PPD spectrum; thus, this
study does not necessarily account for the milder cases.
Introduction
Postpartum depression (PPD) is a nonpsychotic depressive episode occurring in the period
following delivery of a child. Depending on, for example, the inclusion criteria and the quality
of follow-up of women who have given birth, it is reported to affect 5%–15% of all women
after childbirth [1,2], which makes it one of the most common postnatal complications of
childbearing. Left untreated, the disorder can have long-term implications for both mother
and child, including impairment of the child’s development [3–5] and increased risk of long-
term maternal depression [6]. A number of different risk factors for PPD have been identified,
of which the majority are antenatal, personal, and psychosocial factors [3,7–9]. However, such
factors can account for at most a third of the variance in the diagnosis of PPD [10,11], which
could indicate a genetic predisposition, as suggested in some studies [12].
Although evidence exists that there is significant heterogeneity in the timing and persis-
tence of maternal depressive symptomatology [13], very few previous studies have distin-
guished between women with a prior history of psychiatric disease and women with no such
history. This lack of differentiation might partly explain the divergence in findings of etiologi-
cal studies of PPD and in the observed frequency of the disorder, and adds to the ongoing
dispute as to whether PPD is a specific disease entity [14]. Additionally, there is a lack of popu-
lation-based studies investigating the duration of treatment of PPD [15]. It is our assumption
that the PPD phenotype among women with no prior psychiatric history is more homoge-
neous than the phenotype among women with prior psychiatric history. Thus, the main focus
of this study was on women with no prior psychiatric history.
The purpose of this study was, by use of Danish national healthcare and population regis-
ters, to describe the risk of postpartum affective disorder (AD) among women with no prior
psychiatric disorders, the recurrence risk, as well as the duration of treatment in this group.
Methods
In accordance with Danish law, the use of the register-based data in the study was approved by
the Danish Data Protection Agency (no. 2008-54-0472). The study is reported as per STROBE
guidelines (S1 STROBE Checklist). A detailed analysis plan was not written prior to the initia-
tion of the project. However, based on the objectives of this study, we defined all basic analyses
to be undertaken in meetings with all involved parties (epidemiologists, clinician, and statisti-
cians) prior to the receipt of the registry data and before the start of the analyses. We did not
depart from the analysis plan built during these meetings but added post hoc sensitivity
Postpartum affective disorder in women with no prior psychiatric history
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analyses as presented. However, in response to review comments, postpartum antidepressant
treatment was divided post hoc into postpartum medication and PPD hospital contact.
Study cohort
Using the Danish Civil Registration System, we established a cohort comprising all women
born in Denmark who delivered their first live-born singleton child between 1 January 1996
and 31 December 2013 (n = 457,317 women). The Danish personal identification number per-
mits complete follow-up of all persons living in Denmark and accurate linkage of individual-
level information from Denmark’s many mandatory national population-based registers. The
registries used for this study are described in detail in S1 Text. Women with antidepressant use
(ATC: N06) registered in the Danish National Prescription Registry (DNPR) and women reg-
istered in the Psychiatric Central Research Register (PCRR) or the National Patient Registry
(NPR) with mental illnesses (ICD-8: 29, 30; ICD-10: F0–F9) any time prior to their first deliv-
ery were excluded from the cohort. Complete nationwide data on prescriptions were available
in the DNPR starting in 1995, so cohort inclusion began 1 January 1996 in order to have infor-
mation on antidepressant use in the year before delivery in those delivering in early 1996. Fol-
low-up ended 31 December 2014 to include the postpartum period for women delivering in
2013.
Antidepressant treatment—In general and postpartum
In this study, we defined AD as use of antidepressant medication and/or hospital contact for
depression (in- and outpatient). Episodes of postpartum AD were defined as episodes occur-
ring within 6 months after delivery, and all other episodes were referred to as non-postpartum
AD. Women with AD were identified based on information in the NPR, the PCRR, and the
DNPR. Episodes in the DNPR were identified as women filling at least 1 prescription for anti-
depressant medication (ATC: N06). Episodes in the NPR and PCRR were identified as women
having an in- or outpatient contact for a depressive episode, using main diagnoses only (ICD-
8: 2960, 2962, 2968, 2969, 2980, 3004, 3011; ICD-10: F320–F329). For simplicity, outpatients
were also referred to as being admitted and discharged from hospitals, e.g., in the analysis of
duration of treatment. In the analysis of the risk of postpartum AD and the duration of treat-
ment, we did not discriminate as to whether the episodes were defined by use of medication or
hospital contact. In the analysis of the recurrence of AD, we separately analyzed use of postpar-
tum medication and PPD hospital contact after first birth. We interpreted the 2 measures as
treatment for the same overall disorder—although they may represent different levels of sever-
ity of the disorder.
Initiation of treatment was defined as the date of first filled prescription for an antidepres-
sant medication or first hospital admission date, whichever came first. Period of usage was
estimated based on information in the DNPR on number of defined daily doses in the pre-
scription. For refills of prescriptions, a gap of up to 3 months between the calculated last date
of usage of a prescription and the dispensing date of the next prescription was permitted to
allow for differences in drug intake and prescriber habits. If the gap between prescriptions
exceeded 3 months, treatment was considered discontinued, and a new prescription after that
was defined as a new incident episode. Likewise, a 3-month cutoff was applied after the dis-
charge date of hospitalizations for defining a new incident episode.
Statistical analyses
Relative risks of postpartum AD according to parity, year of birth, and mother’s age were esti-
mated by a log-linear binomial regression model—the estimates are mutually adjusted.
Postpartum affective disorder in women with no prior psychiatric history
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The proportion of primiparous women still in treatment by the number of months since
the initiation of treatment was estimated by a Kaplan–Meier analysis. Only women with a
postpartum episode after their first birth were included in this analysis. Women were included
from the first prescription date or first admission date, whichever came first, and were fol-
lowed until the first of the following events: discontinuation of treatment, second birth, death,
emigration, or end of follow-up. This means that, for example, women giving birth in 2012
were followed until the end of 2014 (end of follow-up) unless any of the other above-men-
tioned events occurred prior to end of follow-up.
Rates of postpartum AD after second birth and rates of non-postpartum AD (after first or
second birth) in women with and without a postpartum AD episode after their first birth were
estimated as number of episodes divided by the number of person-years, calculated separately
based on the number of years since latest childbirth. We used a log-linear Poisson regression
model to estimate rate ratios (RRs) for non-postpartum AD in (1) women with a postpartum
AD episode after first birth defined by antidepressant medication and (2) women with a post-
partum AD episode after first birth defined by hospital contact compared to (3) women with
no postpartum AD after first birth. We compared the rate of postpartum and non-postpartum
AD in second-time mothers for these same 3 groups. Women with both postpartum antide-
pressant medication and PPD hospital contact after first birth were classified as PPD hospital
contact cases at the time of the first event, regardless of chronological order of the medication
prescription and the hospital contact. The RR analyses were adjusted for year of birth and
mother’s age. Primiparous women with postpartum AD were followed for non-postpartum
AD after end of treatment, whereas follow-up for primiparous women with no postpartum
AD episode began 6 months after the birthdate of their firstborn. If women gave birth a second
time, they changed status and contributed with person-years to the second-birth analyses. Fol-
low-up for all women continued until the first of the following events: an AD episode, a psychi-
atric diagnosis other than depression, death, emigration, or end of follow-up. Thus, at any
point in the study, no woman, regardless of parity, had any prior history of psychiatric disor-
ders other than a possible postpartum AD after first birth.
Estimation in the supplementary analyses (S2 Text) was performed by the same means as in
the main analyses.
Results
Risk of postpartum AD
Between 1 January 1996 and 31 December 2013, 457,317 women had a first live-born child. Of
these, 273,195 women delivered a second child, and 78,556 women had 3 or more children
during the follow-up period. The proportion of women with a history of postpartum AD and
the proportion of women with a postpartum AD episode are given in Table 1. Overall, 0.6% (n
= 4,550) of childbirths were followed by a postpartum AD episode; 2,389 of these episodes
occurred in primiparous women. The proportion of postpartum AD episodes increased
markedly over the study period, and the risk of an episode was significantly higher among
young mothers: the relative risk for mothers <25 years versus mothers 29–31 years was 1.8
(95% CI 1.6–2.0).
Duration of treatment
Fig 1 shows the estimated proportion of women still in treatment for a postpartum episode by
the number of months since the initiation of treatment among primiparous women (n =
2,389). One year after the first dispensing of antidepressants or hospital contact, 27.9% of the
women were still in treatment; after 4 years, 5.4% remained in treatment. A relatively large
Postpartum affective disorder in women with no prior psychiatric history
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number of women filled only 1 prescription of antidepressants or were admitted only a short
period of time, causing a large decrease in treated women (23%) in the first month. In a
Table 1. Risk of postpartum affective disorder (AD)—Distribution of number of births, women with prior history of postpartum AD, and postpar-
tum AD episodes according to parity, year of birth, and age.
Category Number of
births
Percent of women with history of
postpartum AD (n)
Percent of women with a postpartum AD
episode (n)
Relative Riska (95%
CI)
All births 789,068 0.1 (1,102) 0.6 (4,550)
Parity
1st birth 457,317 — 0.6 (2,389) 1 (ref.)
2nd birth 273,195 0.3 (743) 0.6 (1,680) 1.2 (1.1–1.3)
3+ birth 78,556 0.5 (359) 0.6 (481) 1.2 (1.1–1.3)
Year of birth
1996–2000 179,849 0.03 (46) 0.3 (609) 0.5 (0.4–0.5)
2001–2004 191,965 0.1 (184) 0.6 (1,074) 0.8 (0.8–0.9)
2005–2008 197,011 0.2 (342) 0.7 (1,374) 1.1 (1.0–1–1)
2009–2013 220,243 0.2 (530) 0.7 (1,493) 1 (ref.)
Mother’s age
(years)
<25 129,512 0.1 (99) 0.8 (1,075) 1.8 (1.6–2.0)
25–28 215,954 0.1 (248) 0.6 (1,225) 1.2 (1.1–1.3)
29–31 194,251 0.2 (291) 0.5 (1,019) 1 (ref.)
32–34 140,721 0.2 (268) 0.5 (680) 0.9 (0.8–1.0)
35+ 108,630 0.2 (196) 0.5 (551) 0.9 (0.8–1.0)
Singleton births from 1996–2013 in Denmark in women with no prior psychiatric events.
aAdjusted for parity, year of birth, and mother’s age.
https://doi.org/10.1371/journal.pmed.1002392.t001
Fig 1. The estimated proportion of women in antidepressant treatment by number of months since
the initiation of treatment for a postpartum episode of affective disorder (AD). Primiparous Danish
women with a postpartum AD, 1996–2013, with no prior psychiatric disorders.
https://doi.org/10.1371/journal.pmed.1002392.g001
Postpartum affective disorder in women with no prior psychiatric history
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sensitivity analysis that included only women filling at least 2 prescriptions or being hospital-
ized, this decrease in treated women following the first treatment period was 19%.
Recurrence risk and risk of non-postpartum AD
Fig 2 and Table 2 show the rate of non-postpartum AD in women up to 6 years following first
birth, depending on postpartum AD history (postpartum antidepressant medication, PPD
hospital contact, or no postpartum AD). Table 2 furthermore shows the RR of postpartum AD
after second birth and of non-postpartum AD after first and second birth, depending on post-
partum AD history.
In total, 434,394 women were eligible for follow-up for non-postpartum AD, of whom
2,202 had had a postpartum AD episode. The rate of a new AD episode did not depend on the
type of postpartum AD history, i.e., among women with postpartum antidepressant medica-
tion history (n = 1,820), the rate of new AD episodes was 12.6 per 100 person-years, and for
women with a PPD hospital contact (n = 382), the rate was 12.7 per 100 person-years. For
women with no postpartum AD history, the corresponding rate was 1.8 per 100 person-years.
Adjusted for women’s age and year of birth, and compared to women with no postpartum AD
history, women with a postpartum antidepressant medication history and women with a PPD
hospital contact had a 6.2 and 6.6 times higher rate of new AD episodes, respectively (see
Table 2). The rate of subsequent AD was particularly high in the initial years after the first
birth (women with postpartum antidepressant medication, 0.5 to<2 years: 14.6 per 100 per-
son-years; women with PPD hospital contact, 0.5 to<2 years: 16.5 per 100 person-years). The
Fig 2. Rates of non-postpartum and postpartum affective disorder (AD), depending on postpartum AD history. Left: First-birth rates of non-
postpartum (light grey) AD, depending on postpartum AD history. Right: Second-birth rates of postpartum (dark grey) and non-postpartum (after first 6
months, light grey) AD by number of years since second birth and the women’s history of postpartum AD after first birth. Danish women, 1996–2013,
with no psychiatric disorders prior to first birth. pyrs, person-years.
https://doi.org/10.1371/journal.pmed.1002392.g002
Postpartum affective disorder in women with no prior psychiatric history
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rate decreased with the number of years since the episode (women with postpartum antide-
pressant medication, 6+ years: 5.4 per 100 person-years; women with PPD hospital contact, 6
+ years: 7.8 per 100 person-years), whereas among women with no postpartum AD history,
the rate was relatively constant.
Fig 2 and Table 2 also show the rate of postpartum and non-postpartum AD among women
giving birth for the second time, dependent on whether the woman was treated for a postpar-
tum AD episode after her first birth (postpartum antidepressant medication, PPD hospital
contact, or no postpartum AD). Overall, 273,195 women had a second birth; 743 of these
women had had a postpartum episode after their first birth (Table 1)—122 with a PPD hospital
contact and 621 with postpartum antidepressant medication. Twenty-one percent of women
with a PPD hospital contact after first birth and 15% of women with postpartum antidepres-
sant medication after first birth experienced a recurrent postpartum episode. Out of the
272,452 women with no previous AD, 1,680 (0.6%) women had a first-time episode of postpar-
tum AD. The rate of postpartum AD after the second birth was 1.7 times higher (95% CI 1.1–
2.7) among women with a PPD hospital contact after first birth (55.4 per 100 person-years)
than among women with postpartum antidepressant medication after first birth (35.0 per 100
person-years). The rate of postpartum AD after second birth for women with no history of
postpartum AD was 1.2 per 100 person-years. The rate of AD in the non-postpartum period
after the second birth was, except for the period 0.5 to<1 year, similar for all women with
postpartum AD after first birth, regardless of treatment regime. After adjusting for year of
birth and mother’s age, women with postpartum antidepressant medication after their first
birth had a 26.9 times higher rate (95% CI 21.9–33.2) of recurrent postpartum AD after their
second birth and a 5.0 times higher rate of AD in general (95% CI 4.3–5.8) in the years follow-
ing the second birth, compared to women with no postpartum AD history. In comparison,
women with a PPD hospital contact after first birth had a 46.4 times higher rate (95% CI 31.5–
Table 2. Rates and rate ratios (RRs) of non-postpartum and postpartum affective disorder (AD) after first and second birth depending on postpar-
tum AD status after first birth.
Postpartum AD status after
first birth
First birthc Second birthc
Non-postpartum AD Postpartum AD Non-postpartum AD
N Ratea (95%
CI)
RRb (95%
CI)
N Ratea (95%
CI)
RRb (95% CI) N Ratea (95%
CI)
RRb (95%
CI)
Postpartum antidepressant
medication
1,820 12.6 (11.6–
13.7)
6.2 (5.6–
7.9)
621 35.0 (28.7–
42.8)
26.9 (21.9–
33.2)
491 10.5 (9.0–
12.2)
5.0 (4.3–
5.8)
PPD hospital contact 382 12.7 (10.7–
15.1)
6.6 (5.7–
6.7)
122 55.4 (37.7–
81.4)
46.4 (31.5–
68.4)
86 7.0 (4.7–
10.6)
3.5 (2.4–
5.3)
No postpartum AD 432,192 1.8 (1.8–1.9) 1 (ref.) 272,452 1.2 (1.1–1.2) 1 (ref.) 262,642 2.0 (2.0–2.0) 1 (ref.)
Danish women, 1996–2013, with no psychiatric disorders prior to first birth.
aPer 100 person-years.
bAdjusted for year of birth and mother’s age. To evaluate to what degree the rates in women with postpartum antidepressant medication and PPD hospital
contact differed, we also calculated the RR between postpartum antidepressant medication (ref.) and PPD hospital contact: After first birth, non-postpartum
AD RR = 1.1 (95% CI 0.9–1.3). After second birth, postpartum AD RR = 1.7 (95% CI 1.1–2.7). After second birth, non-postpartum AD RR = 0.7 (95% CI 0.5–
1.1).
cTotal number of person-years (PY): After first birth, non-postpartum period: (1) women with postpartum antidepressant medication, 4,664 PY; (2) women
with a PPD hospital contact, 984 PY; (3) women with no postpartum AD, 1,462,799. After second birth, postpartum period: (1) women with postpartum
antidepressant medication, 271 PY; (2) women with a PPD hospital contact, 47 PY; (3) women with no postpartum AD, 133,881 PY. After second birth, non-
postpartum period: (1) women with postpartum antidepressant medication, 1,624 PY; (2) women with a PPD hospital contact, 328 PY; (3) women with no
postpartum AD, 1,383,944 PY.
PPD, postpartum depression.
https://doi.org/10.1371/journal.pmed.1002392.t002
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68.4) of recurrent postpartum AD and a 3.5 times higher rate of AD in general (95% CI 2.4–
5.3).
Supplementary analyses
In additional analyses, we explored how the main results varied by age and year of giving birth
(see S2 Text). We found that young (<25 years) primiparous mothers seemed be characterized
by a marginally faster treatment period and a higher rate of non-postpartum AD after first
birth than primiparous mothers25 years. A relatively smaller proportion of women having a
postpartum AD episode in the beginning of the study period (1996–2000) were still in treat-
ment a number of years after the episode compared to women having a postpartum AD epi-
sode in the latter part of the study period (2009–2013) (1 year after initiation: 21% versus
32%).
We furthermore tested the sensitivity of the AD definition by varying the length of the post-
partum period and the number of prescriptions required to define an AD episode (S2 Text).
While altering the above measures obviously changed the estimated incidence of postpartum
AD, it did not change the conclusions regarding duration of treatment and recurrence risk. To
further examine our outcome definition of AD as a joint measure encompassing both antide-
pressant medication and hospital contacts, we conducted a number of subanalyses dividing
these 2 groups. Overall, dividing the outcome in 3 groups (the main analyses used 2 groups)
did not change the results markedly.
We also analyzed the conversion rate of postpartum AD to bipolar AD. With follow-up up
to 19 years, we showed that 3.3% of the women with a postpartum AD episode after first birth
converted to bipolar AD. Further details on the additional analyses can be found in S2 Text.
The main focus of this study is on women with no prior psychiatric history. However, in
order to compare the proportion of women with AD in the postpartum period with existing
literature, we also calculated the proportion among “all births,” i.e., the same birth cohort (sin-
gleton, first birth 1996–2013) as the main analyses but with no restriction on previous history
of mental illness. Among the 920,965 births in the “all births” cohort (i.e., 789,068 births to
women with no previous mental illness and 131,897 births to women with previous mental ill-
ness), we found 22,251 (2.4%) AD episodes in the postpartum period.
Discussion
In this nationwide, population-based cohort study, 0.6% of childbirths among women with no
prior history of psychiatric disease resulted in a postpartum AD, defined as a prescription fill
for antidepressant medication and/or hospital contact for depression during the first 6 months
after birth. However, less than 1/3 of the women were still receiving treatment 1 year after
treatment initiation. Compared to women with no episode of postpartum AD after their first
childbirth, women with postpartum antidepressant medication and PPD hospital contact,
respectively, had a 6.2 and 6.6 times increased risk of a non-postpartum AD in the years fol-
lowing first childbirth and a 27 and 46 times higher recurrence rate of postpartum AD follow-
ing a second birth.
To our knowledge, no other study has specifically addressed the duration of antidepressant
use in the postpartum period. We found that a substantial proportion of women filled only 1
prescription for antidepressants, and that less than 28% remained in treatment for 1 year or
more. This could reflect that symptoms subsided faster than expected (although a maintenance
therapy period of at least 6 months is recommended) [16], or that women stopped treatment
due to adverse effects of the medicine or out of concern for the child if they were breastfeeding.
If the latter is the case and women dropped out of treatment, we would expect women to
Postpartum affective disorder in women with no prior psychiatric history
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relapse and treatment to be restarted for months or years following childbirth. In contrast, the
rate of treatment diminishes with time for those who received antidepressant treatment after
their first childbirth (Fig 2). Therefore, our finding most likely reflects the transitory nature of
PPD. This interpretation is supported by a study that investigated different trajectories of peri-
natal depressive symptomatology and found 5 different classes, including a “postpartum
class,” for which depressive symptomatology resolved after 12–24 months postpartum [13].
Women with a history of PPD have an increased risk of experiencing a recurrence in con-
nection with a subsequent delivery [6,17–19]. The population-based nature of our design
allowed us to quantify the recurrence risk as 15% for women with postpartum antidepressant
medication after first birth and 21% for women with a PPD hospital contact after first birth,
or, in other terms, 27 and 46 times higher, respectively, than for women who did not have a
history of postpartum AD after first birth. Thus, women with a PPD hospital contact had an
almost twice as high AD recurrence rate compared to women with postpartum antidepressant
medication. To the extent that PPD hospital contact is an indicator of a more severe PPD epi-
sode compared to medication treatment, the severity of the previous episode seems to signifi-
cantly influence a women’s risk of a recurrent postpartum AD episode. This finding could
perhaps reflect a more proactive treatment strategy among physicians for women with a previ-
ous severe episode of PPD (hospital contact), or simply that the more severe the previous PPD
episode was, the higher the risk of a recurrent postpartum AD episode—a common predispos-
ing factor underlying the risk of developing PPD in a dose–response relationship.
In the “all births” cohort (not restricting on previous mental history), we found that 2.4% of
women had a postpartum AD episode; we considered these likely to have experienced PPD.
There is evidence that the majority of PPD episodes are never diagnosed and treated [20,21].
An American study found that only 15% of postpartum women who, according to interview,
had experienced a mood disorder during the first year after childbirth had sought help, had
been prescribed medications, or had had hospital contact because of their problem [22]. If gen-
erally applicable, a postpartum AD risk of 2.4% as measured in our study would correspond to
an underlying risk of 16% of PPD, which is consistent with the 10%–15% reported in studies
on PPD that have relied primarily on self-reports [1,21,23,24]. A systematic study of 6,790
Danish women who had given birth showed that only 6% had PPD according to the Edinburg
Postnatal Depression Scale, so it cannot be ruled out that the prevalence of PPD is lower in
Denmark and similar countries with a developed welfare system than in other countries
[24,25]. Using the same assumptions for women with no previous mental history, the observed
proportion of women receiving postpartum AD treatment of 0.6% corresponds to an underly-
ing risk of 4% of PPD. Episodes captured by treatment status (i.e., medicine use and/or hospi-
tal contact) without doubt constitute a group of women likely to be at the more severe end of
the PPD spectrum.
Few studies have assessed PPD rate by methods comparable to the present study. Two stud-
ies based on the large prospective Danish National Birth Cohort reported a PPD prevalence of
1.6% and 1.8%, respectively, based on prescriptions of antidepressant medication in the first
year postpartum [26,27], whereas a Danish population-based cohort study of antidepressant
drug use from 12 months prior to childbirth to 12 months postpartum reported a prevalence
of 3.2% [28]. However, none of the aforementioned studies were restricted to women free of
psychiatric disease prior to enrolment, and this may at least in part, along with the differences
in the length of the postpartum period, explain the lower PPD incidence in our study. A popu-
lation-based study from Finland on hospitalization only for a postpartum period of 6 weeks
showed a prevalence of PPD of 0.1% among women with no history of depression [29]. Inter-
estingly, a study from the UK examining the recurrence of PPD showed that for women with a
de novo PPD episode, i.e., no previous depressive events, the risk of further episodes of PPD,
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but not non-postpartum depression, was increased compared to women for whom the PPD
episode was a recurrence of depression [14].
Major strengths of this study include its population-based prospective design, its large size,
and the utilization of high-quality Danish national registers. Healthcare in Denmark is free of
charge, which ensures that all residents, irrespective of economic status, receive appropriate
treatment. The information used was mandatorily reported to the national registries and did
not rely on self-report. This allowed us to estimate absolute AD rates with little bias. To our
knowledge, this is the first population-based cohort study to present risk estimates for PPD in
a population initially free of psychiatric problems, and to provide figures for the duration of
treatment and rate of recurrence after a second birth.
While some of the strengths of this study are based on the use of the national registers, so are
some of the limitations. The use of register data on antidepressant prescriptions to define AD
implies that the women in this study do not necessarily fulfill the DSM-IV diagnostic criteria
for PPD, as this type of medication is often prescribed for indications other than depression,
such as anxiety and obsessive-compulsive disorder, which is why we refer to these women as
being treated for an AD. However, results from a subanalysis including only hospital admissions
showed that the overall conclusions regarding recurrence risk were not markedly different for
this subgroup (see S2 Text). Psychiatric disorders in the postpartum period, especially in the
early postpartum period, may be a marker of possible underlying bipolarity [30]. In our cohort
of women with no psychiatric episodes prior to postpartum AD and with a 19-year follow-up
period, only 3.3% of postpartum AD episodes later converted to bipolar illness (S2 Text).
Different assumptions made in this study are debatable; we have investigated these further
in supplementary analyses (S2 Text). The length of the postpartum period is debatable [31]; we
chose to employ a 6-month postpartum period [32] in the main analyses, and accompany
these with subanalyses using a 3-month and 12-month postpartum period. Further, we also
conducted separate analyses for PPD hospital contacts only, use of antidepressant medication
only, and women who filled at least 2 prescriptions of antidepressants rather than only 1. The
supplementary analyses did not change the overall conclusions regarding the duration of treat-
ment and recurrence risk (S2 Text).
The RRs of recurrence in Table 2 are all adjusted for year of birth and mother’s age, and in
Table 1 also for parity. We did not have information on personal traits or sociodemographic
variables. Thus, it is possible that some of the RRs for recurrence might reflect personal pro-
pensity towards AD.
To conclude, in this study, an antidepressant treatment or depression diagnosis through hos-
pital contact within 6 months after childbirth was observed in 0.6% of childbirths among
women with no previous psychiatric history. The estimated recurrence risk of postpartum AD
was 15% for women with postpartum antidepressant medication after first birth and 21% for
women with a PPD hospital contact after first birth, and the observed risk of treatment for
depression remained increased for several years. However, treatment duration for the majority
of women in the study was short. These population-based figures provide valuable guidance to
physicians treating women with PPD. The study documents the existence of a group of patients
who experience elevated rates of subsequent depression and PPD following an initial postpar-
tum AD episode. It underlines the seriousness of single initial episodes and highlights the neces-
sity of both primary and secondary preventive measures, of which several exist [33,34].
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